FRX has developed the drug and has it will be co-marketed by parke-davis (a subsidary of warner lambert). I think that you would be better off if you invested in WLA because even if the drug goes off patent in a couple of years or if for some reason the drug is not approved, it will not have a major effect on WLA.
WLA makes various revenue sources include prescription drugs Accupril, lipitor($1 Billion in salesin 1997 projected to be $5billion by 2003) , rezulin($450 million in sales in 1997) it also makes sudafed, lubriderm lotion, listerine mouthwash, trident, certs, schick razors, halls, rolaids, ept pregnancy test,actifed, benadryl, chicklets gum, dentyne gum, efferdent, neosporin, nix, tucks pads, and they market zantac 75 which is available over the counter. For more products go to http://www.warner-lambert.com
WLA stock far better than FRX stock
WLA was around $42(split adjusted) in Jan 98, it closed at $78 on 7/15/98
FRX was around $25 in Jan 98 and closed at $35 on 7/15/98
the numbers speak for themselves
I am not saying that FRX is not a good company, but there is too much risk involved when they have just one drug, with wla you will get all the benefits of celexa with less risk!